The information you provide to the chat will be recorded to improve your experience and to contact you. Please read our privacy notice to see how we are processing and protecting your data. Click to view our Cookie Notice.
We'd love your feedback—take a quick survey to help us improve.
How can we help you today?
Search Patheon
Recent searches
Clear History
Suggestions
All Results
Thermo Fisher Scientific
mRNA development and manufacturing services for vaccines and therapeutics
Thermo Fisher Scientific’s flexible mRNA service offering for cutting-edge treatments is backed by decades of experience in advanced therapy development and manufacturing.
mRNA is one of the most significant breakthroughs in modern medicine, demonstrating how a fast, adaptable platform can accelerate the development of more targeted and personalized therapies. Building on the momentum created during the COVID-19 pandemic, mRNA is now expanding beyond vaccines into a broader range of therapeutic applications—opening new possibilities for treating serious diseases.
Thermo Fisher has responded by offering a flexible solutions model for mRNA vaccine and therapeutic development and manufacturing that spans the entire operational value chain, from early cloning services through cold chain logistics.
This fact sheet explores our end-to-end mRNA service options and demonstrates how we integrate upstream and downstream solutions to address gaps in capability or capacity.
Why choose Thermo Fisher Scientific for mRNA CDMO services?
Thermo Fisher Scientific offers integrated mRNA services designed to support programs at any stage of development, including:
- Flexible, à la carte options provide support for programs of any size
- 15,000+ sq. ft. of production space, with potential for expansion
- Over 30 years of experience in advanced therapy manufacturing
- Integrated services allow sponsors to stay with one CDMO partner
Download the fact sheet to learn more about our mRNA offerings.
